Clinical Trials

Head & Neck Cancer Trials

    PSHCI#   P.I.   Title   Notes
                 
    14-006   Mackley   Phase II Randomized Trial of Transoral Surgical Resection followed by Low-dose or Standard-dose IMRT with Biomarker Correlatives in Resectable p16+ Locally Advanced Oropharynx Cancer (E3311)    
                 

RTOG
1221

  14-031    Mackley   Randomized phase II trial of transoral endoscopic head and neck surgery followed by risk-based IMRT and weekly cisplatin VS IMRT and weekly cisplatin for HPV neg oropharynx cancer    
                 
NCI
#9165
  13-031   Almokadem       A Randomized Phase II Trial of ARQ 197 (Tivantinib)/Cetuximab versus Cetuximab in Patients with Recurrent/Metastatic Head and Neck Cancer   Open to accrual 7/5/2013
                 
R1216   13-058   Almokadem   Randomized Phase II/III Trial of Surgery and Postoperative Radiation Delivered with Concurrent Cisplatin Versus Docetaxel Versus Docetaxel and Cetuximab for High-Risk Squamous Cell Cancer of the Head and Neck   Open to accrual 2/20/2014 
                 
PRA/
VRXP-
A202
  13-061   Almokadem   Phase II Recurrent or Metastatic Squamous Cell Carcinoma of the Head & Neck    Open to accrual 3/28/2014